Frank Yocca - Chief Scientific Officer, Bioxcel Therapeutics, Inc
As of March 16, 2022
Frank Yocca Net Worth
- Net worth is estimated to be at least $3.9M
- Owns at least 58,397 units of Bioxcel Therapeutics, Inc stock
- Sold an estimated value of $2.32M in the last 4 years at Bioxcel Therapeutics, Inc
Frank Yocca Trading
- Largest purchase of shares was 6,547 units , worth over $56.76K on August 14, 2019
- Largest sale of shares was 15,000 units , worth over $865.15K on February 18, 2021
- In total has made about 12 transactions over 4 years
- Usually trades in March, with the busiest year in 2018 and 2021
Frank Yocca
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Frank Yocca Mailing Address
- Mailing address is 780 East Main Street C/o Bioxcel Therapeutics, Inc. Branford CT 06405 CT
Bioxcel Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Vimal Mehta, Ph.D. | 2020 | $890,000 | - | $8,122,500 | $556,250 | $7,800 | $9,576,550 |
| Vimal Mehta, Ph.D. | 2019 | $459,000 | - | $1,269,131 | $233,000 | $7,800 | $1,968,931 |
| William P. Kane, Jr. | 2020 | $245,455 | - | $4,185,500 | $138,699 | - | $4,569,654 |
| Reina Benabou, M.D., Ph.D. | 2020 | $197,443 | - | $2,462,400 | $76,341 | - | $2,736,184 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1720893/000110465921055605/tm212482-3_def14a.htm
Bioxcel Therapeutics, Inc Insider Trading
- The most recent transaction was 473,250 units sold on June 29, 2021 by Vimal Mehta worth over $14.59M
- In the last 3 years, insiders at Bioxcel Therapeutics, Inc sold an estimated value of $131.43M and bought an estimated value of $19.96M
- The most active traders are Vimal Mehta, CEO and President, Frank Yocca, Chief Scientific Officer, and Peter Mueller, Director
- Insider trading is most common in March, with the busiest year in 2021
BioXcel Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||